JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
-
Halozyme Therapeutics (HALO) PT Raised to $21 at JMP Securities
-
Halozyme Therapeutics To Present At Upcoming Healthcare Conferences
-
Halozyme Therapeutics Announces Completion Of Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares
-
Halozyme Therapeutics (HALO) Prices 10M Share Offering at $12.50/Sh
-
Halozyme Therapeutics Prices Public Offering Of Common Stock
-
Pre-Open Stock Movers 01/06: (ETRM) (OGXI) (STML) Higher; (RT) (GIII) (REGN) Lower (more...)
-
Halozyme Therapeutics To Present At The JMP Securities 2015 Life Sciences Conference
-
Halozyme Therapeutics' (HALO) Price Target Raised to $21 at JMP
-
Unusual 11 Mid-Day Movers 10/18: (AGEN) (URRE) (HALO) Higher; (TSON) (CROX) (APEI) Lower
-
Morning Movers 10/18: (HALO) (CHUX) (HGSI) Higher; (CROX) (TSON) (HSP) (ACPW) (EDU) Lower
-
JMP Securities Upgrades Halozyme Therapeutics (HALO) to Market Outperform
-
JMP Starts MannKind (MNKD) at Outperform, Biodel (BIOD), Halozyme (HALO) at Market Perform

